Calcium and Nascobal drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Calcium (calcium) and Nascobal (cyanocobalamin). Common drug interactions include gastrointestinal disorder among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Calcium and Nascobal. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Calcium?

Calcium has active ingredients of calcium. It is often used in osteoporosis. eHealthMe is studying from 184,201 Calcium users. Check the latest studies of Calcium.

What is Nascobal?

Nascobal has active ingredients of cyanocobalamin. eHealthMe is studying from 462 Nascobal users. Check the latest studies of Nascobal.



On Jul, 11, 2026

16 people who take Calcium and Nascobal together, and have interactions are studied.

Calcium and Nascobal drug interactions.

What are the common drug interactions of Calcium and Nascobal, by gender? *:

female:

  1. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  2. Full blood count decreased
  3. Gingival bleeding (bleeding gums)
  4. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
  5. Arthralgia (joint pain)
  6. Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
  7. Diplopia (double vision)
  8. Dizziness
  9. Fatigue (feeling of tiredness)
  10. Flushing (the warm, red condition of human skin)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Pneumonia
  4. Upper respiratory tract infection
  5. Chronic kidney disease
  6. Emotional distress
  7. Fatigue (feeling of tiredness)
  8. General physical health deterioration (weak health status)
  9. Pain
  10. Quality of life decreased

What are the common drug interactions of Calcium and Nascobal, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Chronic kidney disease
  4. Emotional distress
  5. Fatigue (feeling of tiredness)
  6. General physical health deterioration (weak health status)
  7. Pain
  8. Quality of life decreased
  9. Renal failure (kidney dysfunction)
  10. Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)

40-49:

  1. Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins)

50-59:

  1. Neuroendocrine tumour (a tumour that forms from cells that release hormones into the blood in response to a signal from the nervous system)
  2. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Full blood count decreased
  5. Gingival bleeding (bleeding gums)
  6. Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)

60+:

  1. Diplopia (double vision)
  2. Dizziness
  3. Influenza
  4. Myalgia (muscle pain)
  5. Pneumonia
  6. Upper respiratory tract infection
  7. Vision blurred

What are the existing conditions these people have? *

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 25.00%
  2. Hiv Infection: 3 people, 18.75%
  3. High Blood Cholesterol: 2 people, 12.50%
  4. Vitamin B12 Deficiency: 1 person, 6.25%
  5. Urinary Retention (the inability to completely or partially empty the bladder): 1 person, 6.25%
  6. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 6.25%
  7. Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 6.25%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.25%
  9. High Blood Pressure: 1 person, 6.25%
  10. Hypersensitivity: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Calcium and Nascobal?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Calcium and Nascobal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nascobal:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Calcium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nascobal and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on calcium and cyanocobalamin (the active ingredients of Calcium and Nascobal, respectively), and Calcium and Nascobal (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: